Literature DB >> 29458120

Major Role for TRPV1 and InsP3R in PAR2-Elicited Inflammatory Mediator Production in Differentiated Human Keratinocytes.

Olivier Gouin1, Killian L'Herondelle2, Paul Buscaglia3, Christelle Le Gall-Ianotto2, Réginald Philippe3, Nelig Legoux3, Olivier Mignen3, Virginie Buhé2, Raphael Leschiera2, Mehdi Sakka2, Nathalie Kerfant4, Jean-Luc Carré2, Raphaele Le Garrec2, Luc Lefeuvre5, Nicolas Lebonvallet2, Laurent Misery6.   

Abstract

PAR2 activation in basal keratinocytes stimulates inflammation via the Ca2+-dependent production of mediators such as IL-1β, TNF-α, and TSLP. In this study, we investigated PAR2 calcium signaling and the consequent production of inflammatory mediators in differentiated human primary keratinocytes (DhPKs). Stimulation with the PAR2-activating peptide SLIGKV promoted Ca2+ store depletion in both undifferentiated human primary keratinocytes and DhPKs. SLIGKV-evoked Ca2+ store depletion did not trigger the store-operated Ca2+ entry (i.e., SOCE) through ORAI1 in DhPKs compared with undifferentiated human primary keratinocytes. The inhibition of phospholipase C and the concomitant inhibition of TRPV1 and inositol triphosphate receptor in DhPKs abrogated the SLIGKV-evoked Ca2+ store depletion; NF-κB activity; and the production of inflammatory mediators such as IL-1β, TNF-α, and TSLP. Taken together, these results indicate a key role for both InsP3R and TRPV1 in Ca2+ internal stores in the PAR2-evoked Ca2+ release and consequent skin inflammation in DhPKs. These findings may provide clues to understanding the pathological role of DhPKs in skin disorders in which PAR2 is known to be involved, such as atopic dermatitis, Netherton syndrome, and psoriasis.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29458120     DOI: 10.1016/j.jid.2018.01.034

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.

Authors:  Jiahui Zhao; Admire Munanairi; Xian-Yu Liu; Jie Zhang; Linghan Hu; Meiqin Hu; Dingfang Bu; Lingling Liu; Zhiqiang Xie; Brian S Kim; Yong Yang; Zhou-Feng Chen
Journal:  J Invest Dermatol       Date:  2020-01-29       Impact factor: 8.551

2.  A re-innervated in vitro skin model of non-histaminergic itch and skin neurogenic inflammation: PAR2-, TRPV1- and TRPA1-agonist induced functionality.

Authors:  N Lebonvallet; J W Fluhr; C Le Gall-Ianotto; R Leschiera; M Talagas; A Reux; A Bataille; C Brun; T Oddos; J-P Pennec; J-L Carré; L Misery
Journal:  Skin Health Dis       Date:  2021-09-30

3.  PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models.

Authors:  Travis P Barr; Chris Garzia; Srijoy Guha; Elizabeth K Fletcher; Nga Nguyen; Adam J Wieschhaus; Lluis Ferrer; Lidija Covic; Athan Kuliopulos
Journal:  J Invest Dermatol       Date:  2018-10-01       Impact factor: 8.551

4.  Heterologous calcium-dependent inactivation of Orai1 by neighboring TRPV1 channels modulates cell migration and wound healing.

Authors:  Carlos Ernesto Bastián-Eugenio; Arlette Bohórquez-Hernández; Jonathan Pacheco; Alicia Sampieri; Alexander Asanov; Jose Pablo Ocelotl-Oviedo; Adán Guerrero; Alberto Darszon; Luis Vaca
Journal:  Commun Biol       Date:  2019-03-04

5.  Calcium Increase and Substance P Release Induced by the Neurotoxin Brevetoxin-1 in Sensory Neurons: Involvement of PAR2 Activation through Both Cathepsin S and Canonical Signaling.

Authors:  Ophélie Pierre; Maxime Fouchard; Paul Buscaglia; Nelig Le Goux; Raphaël Leschiera; Olivier Mignen; Joachim W Fluhr; Laurent Misery; Raphaële Le Garrec
Journal:  Cells       Date:  2020-12-17       Impact factor: 6.600

6.  Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.

Authors:  Nurit P Azouz; Andrea M Klingler; Purnima Pathre; John A Besse; Netali Ben Baruch-Morgenstern; Adina Y Ballaban; Garrett A Osswald; Michael Brusilovsky; Jeff E Habel; Julie M Caldwell; Mario A Ynga-Durand; Pablo J Abonia; Yueh-Chiang Hu; Ting Wen; Marc E Rothenberg
Journal:  Sci Transl Med       Date:  2020-05-27       Impact factor: 17.956

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.